Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
25.32
+0.37 (1.48%)
Nov 13, 2026, 4:00 PM EST - Market closed
Collegium Pharmaceutical Employees
Collegium Pharmaceutical had 423 employees as of December 31, 2025. The number of employees increased by 66 or 18.49% compared to the previous year. That makes Collegium Pharmaceutical the 21,337th largest employer in the world and 2,797th in the United States.
Employees
423
Change (1Y)
66
Growth (1Y)
18.49%
Revenue / Employee
$1,927,154
Profits / Employee
$90,229
Market Cap
786.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 423 | 66 | 18.49% |
| Dec 31, 2024 | 357 | 160 | 81.22% |
| Dec 31, 2023 | 197 | -10 | -4.83% |
| Dec 31, 2022 | 207 | 55 | 36.18% |
| Dec 31, 2021 | 152 | -82 | -35.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,379 |
| Phibro Animal Health | 2,605 |
| Amphastar Pharmaceuticals | 1,976 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Kamada | 462 |
| Harrow | 373 |
| Evolus | 365 |
COLL News
- 18 hours ago - Collegium Pharmaceutical price target lowered to $41 from $48 at Barclays - TheFly
- 7 days ago - Collegium Pharmaceutical price target lowered to $28 from $43 at Piper Sandler - TheFly
- 8 days ago - Collegium Pharmaceutical announces $50M accelerated share repurchase program - TheFly
- 8 days ago - Collegium Pharmaceutical reports Q3 EPS $1.96, consensus $1.86 - TheFly
- 8 days ago - Collegium Pharmaceutical Earnings Call Transcript: Q3 2026 - Transcripts
- 8 days ago - Collegium Pharmaceutical Earnings release: Q3 2026 - Filings
- 8 days ago - Collegium Pharmaceutical Quarterly report: Q3 2026 - Filings
- 8 days ago - Collegium Pharmaceutical Slides: Q3 2026 - Filings